Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport.
about
Cholesterol diet withdrawal leads to an initial plaque instability and subsequent regression of accelerated iliac artery atherosclerosis in rabbitsPrevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.Perspectives and opportunities for nanomedicine in the management of atherosclerosis.Augmentation of neovascularization in murine hindlimb ischemia by combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells transplantation.Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea.Exercise improves immune function, antidepressive response, and sleep quality in patients with chronic primary insomnia.Transcriptome analysis of genes regulated by cholesterol loading in two strains of mouse macrophages associates lysosome pathway and ER stress response with atherosclerosis susceptibilityHIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells.Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1α activation: a novel aspect of angiogenesis in atherosclerosis.Acute coronary eventsCirculating endothelial and progenitor cells: Evidence from acute and long-term exercise effectsVulnerable plaque: from bench to bedside; local pacification versus systemic therapy.Cardiovascular defense challenges at the basic, clinical, and population levelsRole of Haptoglobin in Health and Disease: A Focus on Diabetes.Endothelial progenitor cells: quo vadis?From treating complex coronary artery disease to promoting cardiovascular health: therapeutic transitions and challenges, 2010-2020.Cholesterol--a biological compound as a building block in bionanotechnology.Exercise mitigates the adverse effects of hyperhomocysteinemia on macrophages, MMP-9, skeletal muscle, and white adipocytes.Hp: an inflammatory indicator in cardiovascular disease.An integrated approach for the mechanisms responsible for atherosclerotic plaque regressionNifedipine enhances cholesterol efflux in RAW264.7 macrophages.Vascular Health Profile predicts cardiovascular outcomes in patients with diabetes.Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity.Low-fat versus low-carbohydrate diets, weight loss, vascular health, and prevention of coronary artery disease: the evidence, the reality, the challenge, and the hope.Trichosanthes pericarpium Aqueous Extract Enhances the Mobilization of Endothelial Progenitor Cells and Up-regulates the Expression of VEGF, eNOS, NO, and MMP-9 in Acute Myocardial Ischemic Rats.Rosuvastatin for Reduction of Myocardial Damage during Coronary Angioplasty - the Remedy Trial.Microwave-driven synthesis of bisphosphonate nanoparticles allows in vivo visualisation of atherosclerotic plaqueSonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPARγ-LXRα-ABCA1/ABCG1 pathway and promotes cholesterol efflux in advanced plaque
P2860
Q28534496-4C76CA98-E55D-484B-8966-3F03706F55A8Q30357131-CF70DFCE-387E-49CA-9D9E-7E3B75F1BA29Q30455490-24D4EABC-3675-4B54-A7D2-3B1FB8101169Q33694021-CD3858F2-BAD8-4A35-AC7F-252F125344CEQ33988152-3AD0C786-066A-4AB0-B5B5-73710EDF0A6FQ34307326-08D98410-1D16-48FD-8388-5B3C71E67445Q34738282-2F0BCCCD-EAAF-4E21-817C-929D729C5E7BQ35068359-43898251-99F4-4087-8A7E-243FA98DBADAQ35101457-D68D25DA-12C0-471E-8B03-2103020C4CE2Q35878289-C6ECA8E0-0AAF-47BE-BD39-8FF72C57A387Q36490364-02AFB1DC-FDCC-4152-8C1A-CAE3DABC1ADEQ36612448-E20B92F0-1FEB-42F7-82A6-60F075524572Q37118290-A42018CC-CBD8-4048-ABD6-A6B6904B56D1Q37248191-094E5945-4123-4672-8289-A42E75CDDC0BQ37776785-33FA7930-7ECA-47B5-A96C-B96790F865B2Q37928904-E25BB706-5523-4B53-95D1-8F60F61A2F61Q38061564-2A30821F-6D94-483E-A2E0-9ABA18D905A6Q38219764-09B5730D-8782-4669-B8C0-FF3DBD01D441Q38864675-372A7C2E-450E-4223-A41F-77271B59BE7EQ38963714-AE0AB455-65DB-4313-B363-1EB7321E57E9Q39132949-373C9BAC-8AA2-4D80-8BD4-16E20C1F3221Q40324178-F461BBB1-F90F-44E3-A48E-4664EDD4545DQ41813965-1EBD8A59-E925-4DBA-AB8A-ABAEE2DD48B2Q47408907-BF7B5F46-65F5-4188-8428-99D1E1A042F8Q49539832-D595A260-BC85-472E-B0F6-36BA554B1A52Q53594601-1FD29B9C-999B-4E32-B176-6217B528D089Q56985914-E2ADD8E2-D3C5-4E4E-86B8-66215793F2DAQ59138144-B6577EE3-EFC7-462A-B8F7-C95008D2BDD1
P2860
Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Promoting mechanisms of vascul ...... reverse cholesterol transport.
@ast
Promoting mechanisms of vascul ...... reverse cholesterol transport.
@en
Promoting mechanisms of vascul ...... reverse cholesterol transport.
@nl
type
label
Promoting mechanisms of vascul ...... reverse cholesterol transport.
@ast
Promoting mechanisms of vascul ...... reverse cholesterol transport.
@en
Promoting mechanisms of vascul ...... reverse cholesterol transport.
@nl
prefLabel
Promoting mechanisms of vascul ...... reverse cholesterol transport.
@ast
Promoting mechanisms of vascul ...... reverse cholesterol transport.
@en
Promoting mechanisms of vascul ...... reverse cholesterol transport.
@nl
P2093
P1476
Promoting mechanisms of vascul ...... reverse cholesterol transport.
@en
P2093
Javier Sanz
Pedro R Moreno
Valentin Fuster
P304
P356
10.1016/J.JACC.2009.02.057
P407
P577
2009-06-01T00:00:00Z